Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet available therapies only modestly improve clinical outcomes. Observational studies report independent associations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of ESRD,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Soc Nephrol
Autors principals: Isakova, Tamara, Ix, Joachim H., Sprague, Stuart M., Raphael, Kalani L., Fried, Linda, Gassman, Jennifer J., Raj, Dominic, Cheung, Alfred K., Kusek, John W., Flessner, Michael F., Wolf, Myles, Block, Geoffrey A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2015
Matèries:
Up Front Matters
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587706/
https://ncbi.nlm.nih.gov/pubmed/25967123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015020117
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars